Pharmac NZ Decision to Fund Fosfomycin for UTIs

Pharmac | Te Pātaka Whaioranga has announced that fosfomycin (branded as UroFos) will be funded in the community from 1 November 2024.

This decision will allow New Zealanders to access funded fosfomycin treatment in the community, reducing the need for people to be treated for urinary tract infections (UTIs) in the hospital.